Your session is about to expire
← Back to Search
EGF Mapping and Ablation Therapy for Atrial Fibrillation (RESOLVE-AF Trial)
RESOLVE-AF Trial Summary
This trial will test the safety and effectiveness of a system for mapping and treating types of atrial fibrillation. It will also measure how well it predicts outcomes.
RESOLVE-AF Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRESOLVE-AF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RESOLVE-AF Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants are joining this clinical trial?
"Ablacon, Inc., the sponsor of this clinical trial, seeks 400 patients to meet the study's inclusion criteria. The medical trial will be conducted at multiple sites, such as Piedmont Health in Athens, Georgia and University of Utah in Salt Lake City, Utah."
Is there still capacity for new participants in this clinical trial?
"As evidenced on clinicaltrials.gov, this ongoing medical investigation is actively recruiting patients for participation. The initial advertisement was posted on October 23rd 2023 with the most recent update taking place November 29th of that same year."
Is my eligibility for this experiment adequate to join it?
"Prerequisites for this clinical trial include atrial fibrillation and age between 18 to 80. There is room for up to 400 participants in the research study."
Does this research trial accept participants who are over fifty years old?
"Eligibility for this trial is limited to those 18 years of age or older and no more than 80."
Are there multiple locations in the US that have commenced this research project?
"This research is taking place across 5 locations - two of which are Athens, Salt Lake City and Charlottesville. Selecting the closest site to your residence is recommended in order to curtail travel needs if you decide to join this trial."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger